Director · Veraxa Biotech AG - Post de-SPAC · Ordinary Shares
Side
BUY
Value
$33K
Shares
30.0K
Price
$1.09
Executed
Oct 20, 2026
Disclosed
Oct 21, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Oct 20 executedOct 21, 2026 disclosed
VRXA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Ziegler Christoph Samuel filed this Form 4 reporting a open-market purchase of VRXA on Oct 20, 2026. It became public on Oct 21, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Ziegler Christoph Samuelcik:0002123272
Issuer
Veraxa Biotech AG - Post de-SPACcik:0002079109
Revision history · 0
No field has changed since this record was first ingested.
